<Summary id="CDR0000062878" LegacyPDQID="3463">
	<SummaryMetaData>
		<SummaryType>Treatment</SummaryType>
		<SummaryAudience>Patients</SummaryAudience>
		<SummaryLanguage>English</SummaryLanguage>
		<SummaryDescription>Expert-reviewed information summary about the treatment of unusual cancers of childhood.</SummaryDescription>
		<SummaryURL xref="http://cancer.gov/cancertopics/pdq/treatment/unusual-cancers-childhood/Patient">Unusual Cancers of Childhood (PDQ®): Treatment</SummaryURL>
		<MainTopics>
			<TermRef ref="CDR0000038073">unusual cancers of childhood</TermRef>
		</MainTopics>
	</SummaryMetaData>
	<SummaryTitle>Unusual Cancers of Childhood</SummaryTitle>
	<SummarySection id="_109">
		<SectMetaData>
			<SpecificDiagnosis ref="CDR0000038073">unusual cancers of childhood</SpecificDiagnosis>
			<SectionType>Prognosis--legacy</SectionType>
		</SectMetaData>
		<Title>General Information</Title>
		<Para id="_3">The <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> discussed in this summary are many and different, and the discussion
is arranged in descending order from tumors of the head and neck to tumors of
the <GlossaryTermRef href="CDR0000044093">urinary</GlossaryTermRef> system and skin.  All of these <GlossaryTermRef href="CDR0000045333">cancers</GlossaryTermRef> are rare enough that most
<GlossaryTermRef href="CDR0000046245">pediatric</GlossaryTermRef> hospitals might see fewer than two cases in a year.  Most of these
tumors are more frequent in adults with cancer; thus, much of the information
about these tumors may also be sought through sources relevant to adults with
these tumors.
</Para>
	</SummarySection>
	<SummarySection id="_4">
		<Title>Head and Neck Cancers</Title>
		<Para id="_5">Head and neck <GlossaryTermRef href="CDR0000045333">cancers</GlossaryTermRef> include cancers of the nose and <GlossaryTermRef href="CDR0000439429">throat,</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000046036">thyroid</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000046634">tumors,</GlossaryTermRef>
mouth cancer, <GlossaryTermRef href="CDR0000046196">salivary gland</GlossaryTermRef> cancer,  cancer of the <GlossaryTermRef href="CDR0000046026">larynx</GlossaryTermRef> (or voice box), and upper <GlossaryTermRef href="CDR0000044490">respiratory tract</GlossaryTermRef>. 
These cancers are discussed below.
</Para>
		<SummarySection id="_6">
			<Title>Cancer of the Nose and Throat</Title>
			<Para id="_7">
				<GlossaryTermRef href="CDR0000045333">Cancers</GlossaryTermRef> that start in the lining of the <GlossaryTermRef href="CDR0000044061">nasal</GlossaryTermRef> cavity and <GlossaryTermRef href="CDR0000439429">throat</GlossaryTermRef> are called
<GlossaryTermRef href="CDR0000046025">nasopharyngeal</GlossaryTermRef> cancers.  The <GlossaryTermRef href="CDR0000046145">incidence</GlossaryTermRef> of this <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> is approximately 1 in
100,000 persons younger than 20 years in the United States. 
</Para>
			<Para id="_8">Nasopharyngeal cancer occurs in association with <GlossaryTermRef href="CDR0000045684">Epstein-Barr virus</GlossaryTermRef> (EBV)
<GlossaryTermRef href="CDR0000045364">infection,</GlossaryTermRef> the <GlossaryTermRef href="CDR0000045941">virus</GlossaryTermRef> associated with infectious mononucleosis.  This cancer
most frequently spreads to <GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef> in the neck, which may alert the
patient, parent, or <GlossaryTermRef href="CDR0000390246">physician</GlossaryTermRef> to the presence of this tumor.  The tumor may
spread to the nose, mouth, and <GlossaryTermRef href="CDR0000046061">pharynx,</GlossaryTermRef> causing snoring, nosebleeds,
<GlossaryTermRef href="CDR0000044954">obstruction</GlossaryTermRef> of the Eustachian tubes, or hearing loss.  It may invade the base
of the skull, causing cranial <GlossaryTermRef href="CDR0000373935">nerve</GlossaryTermRef> palsy or difficulty with movements of the
jaw (trismus).  The cancer may spread to distant sites such as the bones,
<GlossaryTermRef href="CDR0000270740">lungs,</GlossaryTermRef> and <GlossaryTermRef href="CDR0000046312">liver.</GlossaryTermRef>
			</Para>
			<Para id="_9">Treatment combines the use of <GlossaryTermRef href="CDR0000045570">surgery,</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000045214">chemotherapy.</GlossaryTermRef> 
Nasopharyngeal cancer generally has spread to bones of the skull and to lymph
nodes in the neck at the time of <GlossaryTermRef href="CDR0000046450">diagnosis;</GlossaryTermRef> thus, the principal role of surgery
is to obtain adequate diagnostic material from a <GlossaryTermRef href="CDR0000045164">biopsy</GlossaryTermRef> of the involved lymph
node or the <GlossaryTermRef href="CDR0000045847">primary site</GlossaryTermRef>. Studies show that combining chemotherapy with radiation therapy is the most effective treatment for this tumor. Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on <SummaryRef href="CDR0000062966" url="/cancertopics/pdq/treatment/nasopharyngeal/Patient">Nasopharyngeal
Cancer Treatment</SummaryRef> for more information.</Para>
		</SummarySection>
		<SummarySection id="_110">
			<Title>Esthesioneuroblastoma</Title>
			<Para id="_111">Esthesioneuroblastoma (olfactory <GlossaryTermRef href="CDR0000045418">neuroblastoma</GlossaryTermRef>) is a very rare, small <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> that begins in the olfactory bulb (the <GlossaryTermRef href="CDR0000257523">organ</GlossaryTermRef> responsible for the sense of smell) located in the front part of the brain.  Most children have a tumor in the nose or <GlossaryTermRef href="CDR0000439429">throat</GlossaryTermRef> at the time of diagnosis.  The tumor may extend into the eyes, sinuses, and the front part of the brain.  Esthesioneuroblastoma occurs more often in boys and usually appears during adolescence. The disease seldom spreads to other parts of the body.  Treatment for this <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> is usually <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef>; <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef> may also be used. Newer treatments may include sinus surgery done through an <GlossaryTermRef href="CDR0000046428">endoscope</GlossaryTermRef> combined with <GlossaryTermRef href="CDR0000044452">radiosurgery</GlossaryTermRef> that targets  the tumor.</Para>
		</SummarySection>
		<SummarySection id="_10">
			<Title>Thyroid Tumors</Title>
			<Para id="_11">
				<GlossaryTermRef href="CDR0000046634">Tumors</GlossaryTermRef> of the <GlossaryTermRef href="CDR0000046036">thyroid</GlossaryTermRef> (a <GlossaryTermRef href="CDR0000046386">gland</GlossaryTermRef> near the <GlossaryTermRef href="CDR0000044379">windpipe</GlossaryTermRef> that produces <GlossaryTermRef href="CDR0000044558">thyroid hormone</GlossaryTermRef>,
which helps regulate growth and <GlossaryTermRef href="CDR0000046173">metabolism</GlossaryTermRef>) are classified as <GlossaryTermRef href="CDR0000046217">adenomas</GlossaryTermRef> or
<GlossaryTermRef href="CDR0000045963">carcinomas.</GlossaryTermRef>  Adenomas are <GlossaryTermRef href="CDR0000045614">benign</GlossaryTermRef> (noncancerous) growths that may cause
enlargement of all or part of the gland, which extends to both sides of the
neck and can be quite large.  Some of these tumors may secrete <GlossaryTermRef href="CDR0000045713">hormones.</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000046628">Transformation</GlossaryTermRef> to a <GlossaryTermRef href="CDR0000045772">malignant</GlossaryTermRef> carcinoma (cancer) may occur in some <GlossaryTermRef href="CDR0000046476">cells,</GlossaryTermRef> which
then may grow and spread to <GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef> in the neck or to the <GlossaryTermRef href="CDR0000270740">lungs</GlossaryTermRef>.
</Para>
			<Para id="_12">  Thyroid carcinomas are rare and occur most often in girls. This cancer usually appears as a lump or mass in the thyroid with possible swelling of the <GlossaryTermRef href="CDR0000044489">lymph glands</GlossaryTermRef> in the neck. </Para>
			<Para id="_13">
				<GlossaryTermRef href="CDR0000045570">Surgery</GlossaryTermRef> is the treatment required for all thyroid <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef>.  This is usually removal of all or nearly all of the thyroid and nearby lymph nodes in the neck. Treatment with a <GlossaryTermRef href="CDR0000046550">radioactive</GlossaryTermRef> form of <GlossaryTermRef href="CDR0000044548">iodine</GlossaryTermRef> is given after surgery to destroy cancer cells and thyroid <GlossaryTermRef href="CDR0000046683">tissue</GlossaryTermRef> that remain. After
surgery and treatment with radioactive iodine, <GlossaryTermRef href="CDR0000046127">hormone replacement therapy</GlossaryTermRef> must be given to compensate for the lost
thyroid <GlossaryTermRef href="CDR0000045713">hormone</GlossaryTermRef>.   Regular checkups are required
to determine whether the cancer has spread to the lungs.  Patients with thyroid
cancer generally have an excellent survival with relatively few <GlossaryTermRef href="CDR0000046580">side effects</GlossaryTermRef>. 
Thyroid tumors that <GlossaryTermRef href="CDR0000046556">recur</GlossaryTermRef> (come back) are usually treated with radioactive iodine. Even patients with tumor that has spread to the lungs may expect no decrease in
life span after appropriate treatment. (Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult
<SummaryRef href="CDR0000062709" url="/cancertopics/pdq/treatment/thyroid/Patient">Thyroid Cancer Treatment</SummaryRef> for more information.)
</Para>
		</SummarySection>
		<SummarySection id="_14">
			<Title>Oral (Mouth) Cancers</Title>
			<Para id="_15">
				<GlossaryTermRef href="CDR0000445073">Oral cancer</GlossaryTermRef> in children or in adolescents is extremely rare.  Most oral <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> are <GlossaryTermRef href="CDR0000045614">benign</GlossaryTermRef> (not cancer). <GlossaryTermRef href="CDR0000045772">Malignant</GlossaryTermRef> tumors include <GlossaryTermRef href="CDR0000045368">lymphomas</GlossaryTermRef> (often <GlossaryTermRef href="CDR0000045203">Burkitt's lymphoma</GlossaryTermRef>) and <GlossaryTermRef href="CDR0000045562">sarcomas</GlossaryTermRef> (<GlossaryTermRef href="CDR0000045882">soft tissue</GlossaryTermRef> tumors). Oral <GlossaryTermRef href="CDR0000046595">squamous cell carcinoma</GlossaryTermRef> (cancer of the thin, flat cells lining the mouth)  is the most common type of oral cancer in adults, but is rare in children; adolescents (teens) with oral squamous cell carcinoma should be screened for a condition called <GlossaryTermRef href="CDR0000045499">Fanconi's  anemia</GlossaryTermRef>. Treatment of oral cancer in children may include <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef>.   (Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summaries on adult
<SummaryRef href="CDR0000258025" url="/cancertopics/pdq/treatment/oropharyngeal/Patient">Oropharyngeal Cancer Treatment</SummaryRef> and <SummaryRef href="CDR0000258017" url="/cancertopics/pdq/treatment/lip-and-oral-cavity/Patient">Lip and Oral Cavity Cancer Treatment</SummaryRef> for more information).
</Para>
		</SummarySection>
		<SummarySection id="_16">
			<Title>Salivary Gland Tumors</Title>
			<Para id="_17">
				<GlossaryTermRef href="CDR0000046196">Salivary glands</GlossaryTermRef> are the parts of the mouth and <GlossaryTermRef href="CDR0000439429">throat</GlossaryTermRef> that produce <GlossaryTermRef href="CDR0000257526">saliva.</GlossaryTermRef> 
Many of the <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> in these areas arise in the parotid <GlossaryTermRef href="CDR0000046386">gland</GlossaryTermRef>.  About 15% of
these tumors may arise in the submandibular glands or in the minor salivary
glands under the tongue and jaw.  These tumors are most frequently noncancerous
but on very rare occasions may be <GlossaryTermRef href="CDR0000045772">malignant</GlossaryTermRef> (<GlossaryTermRef href="CDR0000045333">cancerous</GlossaryTermRef>).  The malignant <GlossaryTermRef href="CDR0000046324">lesions</GlossaryTermRef>
include <GlossaryTermRef href="CDR0000046216">adenocarcinoma,</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000044775">undifferentiated</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045963">carcinoma</GlossaryTermRef>, acinic <GlossaryTermRef href="CDR0000046476">cell</GlossaryTermRef> carcinomas,
and mucoepidermoid carcinoma.  These tumors may occur after <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef>
for treatment of primary <GlossaryTermRef href="CDR0000045343">leukemia</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045301">solid tumors</GlossaryTermRef>.  Complete <GlossaryTermRef href="CDR0000045570">surgical</GlossaryTermRef> removal
is the treatment of choice whenever possible, with additional use of radiation
therapy and <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef>.  <GlossaryTermRef href="CDR0000045849">Prognosis</GlossaryTermRef> (outcome) for patients with these tumors
is generally good.  (Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult <SummaryRef href="CDR0000062715" url="/cancertopics/pdq/treatment/salivarygland/Patient">Salivary Gland Cancer
Treatment</SummaryRef> for more information.)
</Para>
		</SummarySection>
		<SummarySection id="_18">
			<Title>Laryngeal Cancer and Papillomatosis</Title>
			<Para id="_19">
				<GlossaryTermRef href="CDR0000045614">Benign</GlossaryTermRef> and especially <GlossaryTermRef href="CDR0000045772">malignant</GlossaryTermRef> (<GlossaryTermRef href="CDR0000045333">cancerous</GlossaryTermRef>) <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> of the <GlossaryTermRef href="CDR0000046026">larynx</GlossaryTermRef> (voice box)
are rare.  Malignant tumors may be associated with benign tumors such as <GlossaryTermRef href="CDR0000045844">polyps</GlossaryTermRef>
and papillomas.  These tumors may cause hoarseness, difficulty swallowing, and
enlargement of the <GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef> of the neck.  <GlossaryTermRef href="CDR0000045872">Rhabdomyosarcoma</GlossaryTermRef> (a malignant
tumor of muscle <GlossaryTermRef href="CDR0000046683">tissue</GlossaryTermRef>) is the most common malignant tumor of the larynx in the
<GlossaryTermRef href="CDR0000046245">pediatric</GlossaryTermRef> age group.  <GlossaryTermRef href="CDR0000046595">Squamous cell carcinoma</GlossaryTermRef> of the larynx should be
managed with <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044971">radiation</GlossaryTermRef>.  <GlossaryTermRef href="CDR0000322858">Laser surgery</GlossaryTermRef> may be the first type of
treatment used for these cancers. 
</Para>
			<Para id="_20">Papillomatosis of the larynx is a benign overgrowth of tissues lining the
larynx.  This condition is not cancerous, but may <GlossaryTermRef href="CDR0000046556">recur</GlossaryTermRef> after treatment. These tumors can cause hoarseness
because of their association with <GlossaryTermRef href="CDR0000046652">wart</GlossaryTermRef>-like <GlossaryTermRef href="CDR0000044502">nodules</GlossaryTermRef> on the <GlossaryTermRef href="CDR0000046650">vocal cords</GlossaryTermRef>; they
may extend into the <GlossaryTermRef href="CDR0000270740">lung</GlossaryTermRef> and develop into cancer in the larynx.  Treatment includes laser surgery. (Refer to the
<GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult <SummaryRef href="CDR0000258016" url="/cancertopics/pdq/treatment/laryngeal/Patient">Laryngeal Cancer Treatment</SummaryRef> for more information.)
</Para>
		</SummarySection>
		<SummarySection id="_115">
			<Title>Respiratory Tract Cancer with Chromosome 15 Changes</Title>
			<Para id="_119">The <GlossaryTermRef href="CDR0000044490">respiratory tract</GlossaryTermRef> includes the nose, <GlossaryTermRef href="CDR0000439429">throat</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046026">larynx</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046623">trachea,</GlossaryTermRef> and <GlossaryTermRef href="CDR0000270740">lungs</GlossaryTermRef>. Respiratory tract <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> may be caused by a specific <GlossaryTermRef href="CDR0000046470">chromosome</GlossaryTermRef> change. Every <GlossaryTermRef href="CDR0000046476">cell</GlossaryTermRef> in the body contains <GlossaryTermRef href="CDR0000045671">DNA</GlossaryTermRef> (<GlossaryTermRef href="CDR0000046391">genetic</GlossaryTermRef> material stored inside chromosomes) that determines how the cell looks and acts. Cancer may develop when part of the DNA from chromosome 15 moves to another chromosome, or when chromosome 15 is broken.  This type of cancer may appear in parts of the airway or in other places along the midline of the body, including the <GlossaryTermRef href="CDR0000046616">thymus,</GlossaryTermRef> the area between the lungs, and the <GlossaryTermRef href="CDR0000046501">bladder.</GlossaryTermRef> It usually cannot be <GlossaryTermRef href="CDR0000318813">cured.</GlossaryTermRef>
			</Para>
		</SummarySection>
	</SummarySection>
	<SummarySection id="_21">
		<Title>Thoracic Cancers</Title>
		<Para id="_22">
			<GlossaryTermRef href="CDR0000046613">Thoracic</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000045333">cancers</GlossaryTermRef> include <GlossaryTermRef href="CDR0000304766">breast</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000045333">cancer,</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000285958">bronchial</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000046217">adenomas,</GlossaryTermRef> bronchial <GlossaryTermRef href="CDR0000044233">carcinoid
tumors</GlossaryTermRef>, pleuropulmonary blastoma, <GlossaryTermRef href="CDR0000046414">esophageal</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000046634">tumors,</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000046002">thymomas,</GlossaryTermRef> tumors of the
heart, and <GlossaryTermRef href="CDR0000044323">mesothelioma.</GlossaryTermRef>  These thoracic cancers are discussed below.
</Para>
		<SummarySection id="_23">
			<Title>Breast Cancer</Title>
			<Para id="_24">Most <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> that involve the <GlossaryTermRef href="CDR0000304766">breast</GlossaryTermRef> during childhood are <GlossaryTermRef href="CDR0000045614">benign</GlossaryTermRef>  (noncancerous) fibroadenomas that can be watched for  change without the need for <GlossaryTermRef href="CDR0000045164">biopsy</GlossaryTermRef>. Rarely, such breast tumors will show <GlossaryTermRef href="CDR0000045772">malignant</GlossaryTermRef> change with  sudden, rapid growth. These  are called <GlossaryTermRef href="CDR0000046035">phyllodes tumors</GlossaryTermRef>, and   require  biopsy or <GlossaryTermRef href="CDR0000045570">surgical</GlossaryTermRef> removal without <GlossaryTermRef href="CDR0000045777">mastectomy</GlossaryTermRef>. Other types of breast cancer have been reported in both males and females younger than 21 years. 
There is an increased lifetime risk of breast cancer in patients who were treated for any cancer with <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef> to the chest area, including female survivors of
<GlossaryTermRef href="CDR0000270800">Hodgkin’s lymphoma</GlossaryTermRef>.   <GlossaryTermRef href="CDR0000045775">Mammograms</GlossaryTermRef> should start at age 25 or 10 years after radiation therapy to the chest, whichever came last.  Treatment options include radiation, <GlossaryTermRef href="CDR0000045214">chemotherapy,</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef>
for children and adolescents with breast cancer. Breast tumors may also occur
as cancers that have spread from other types of cancer such as <GlossaryTermRef href="CDR0000045343">leukemia,</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045872">rhabdomyosarcoma,</GlossaryTermRef>  other <GlossaryTermRef href="CDR0000045562">sarcomas</GlossaryTermRef>,   or <GlossaryTermRef href="CDR0000045368">lymphoma</GlossaryTermRef>, particularly in patients infected with the <GlossaryTermRef href="CDR0000044366">human immunodeficiency virus</GlossaryTermRef> (HIV).(Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult <SummaryRef href="CDR0000062955" url="/cancertopics/pdq/treatment/breast/Patient">Breast
Cancer Treatment</SummaryRef> for more information.)   
</Para>
		</SummarySection>
		<SummarySection id="_25">
			<Title>Bronchial Tumors</Title>
			<Para id="_26">
				<GlossaryTermRef href="CDR0000285958">Bronchial</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> (which are slow-growing <GlossaryTermRef href="CDR0000045333">cancers</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000046623">trachea</GlossaryTermRef> or large <GlossaryTermRef href="CDR0000046493">bronchi,</GlossaryTermRef> the large airways
of the <GlossaryTermRef href="CDR0000270740">lung</GlossaryTermRef>),  are most often  <GlossaryTermRef href="CDR0000044233">carcinoid</GlossaryTermRef> tumors in children. <GlossaryTermRef href="CDR0000045022">Symptoms</GlossaryTermRef> include cough and  spitting up blood, and can sometimes be confused with <GlossaryTermRef href="CDR0000440101">asthma</GlossaryTermRef> symptoms like wheezing, resulting in delayed <GlossaryTermRef href="CDR0000046450">diagnosis</GlossaryTermRef>. Primary treatment  is <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef> to remove the tumor and <GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef> and <GlossaryTermRef href="CDR0000269462">vessels</GlossaryTermRef> where cancer may  spread. The <GlossaryTermRef href="CDR0000045849">prognosis</GlossaryTermRef> for most bronchial tumors in children is excellent, even when the cancer has spread to nearby areas. Rarely, carcinoid tumors develop as <GlossaryTermRef href="CDR0000046053">aggressive</GlossaryTermRef>(fast-growing) cancers that are more likely to spread to other areas of the body by the time they are diagnosed.  For
bronchial carcinoid tumors, neither <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef> nor <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef> is
indicated, unless evidence of <GlossaryTermRef href="CDR0000046710">metastasis</GlossaryTermRef> (spread of cancer to other areas of 
the body) is documented.
Cancers that begin in the <GlossaryTermRef href="CDR0000045682">epithelial</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef> that line the surface of the lung are rare, and tend to be advanced when they are diagnosed. The outcome  for epithelial cancers of the lung depends on how the cells look under a microscope and the <GlossaryTermRef href="CDR0000045885">stage</GlossaryTermRef> of the cancer.</Para>
		</SummarySection>
		<SummarySection id="_27">
			<Title>Pleuropulmonary Blastoma</Title>
			<Para id="_28">Pleuropulmonary blastomas are rare <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> that usually occur under the <GlossaryTermRef href="CDR0000046683">tissue</GlossaryTermRef>
covering the <GlossaryTermRef href="CDR0000270740">lungs.</GlossaryTermRef>  The tumors may <GlossaryTermRef href="CDR0000046556">recur</GlossaryTermRef> or spread, in spite of <GlossaryTermRef href="CDR0000045570">surgical</GlossaryTermRef>
removal.  <GlossaryTermRef href="CDR0000044085">Responses</GlossaryTermRef> to chemotherapy have been reported.  <GlossaryTermRef href="CDR0000044971">Radiation</GlossaryTermRef> may be used
when the tumor cannot be surgically removed.  A <GlossaryTermRef href="CDR0000302456">family history</GlossaryTermRef> of cancer in
close relatives has been noted for many young patients affected by this tumor.
</Para>
		</SummarySection>
		<SummarySection id="_29">
			<Title>Esophageal Tumors</Title>
			<Para id="_30">
				<GlossaryTermRef href="CDR0000045333">Cancer</GlossaryTermRef> of the <GlossaryTermRef href="CDR0000046408">esophagus</GlossaryTermRef> (the muscular tube through which food passes from the
<GlossaryTermRef href="CDR0000439429">throat</GlossaryTermRef> to the <GlossaryTermRef href="CDR0000046604">stomach</GlossaryTermRef>) is rare in the <GlossaryTermRef href="CDR0000046245">pediatric</GlossaryTermRef> age group.  <GlossaryTermRef href="CDR0000045022">Symptoms</GlossaryTermRef> are
related to difficulty in swallowing, and associated weight loss.  Treatment
options for esophageal cancer include either <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef>. 
<GlossaryTermRef href="CDR0000045849">Prognosis</GlossaryTermRef> generally is poor for this cancer, which rarely can be completely
removed by <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef>. (Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult <SummaryRef href="CDR0000062960" url="/cancertopics/pdq/treatment/esophageal/Patient">Esophageal Cancer
Treatment</SummaryRef> for more information.)   
</Para>
		</SummarySection>
		<SummarySection id="_31">
			<Title>Thymomas and Thymic Carcinoma</Title>
			<Para id="_32">A <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> of the <GlossaryTermRef href="CDR0000046616">thymus</GlossaryTermRef> (an <GlossaryTermRef href="CDR0000257523">organ</GlossaryTermRef> in the chest, behind the breastbone) is not
considered a <GlossaryTermRef href="CDR0000046002">thymoma</GlossaryTermRef> (cancer) or a <GlossaryTermRef href="CDR0000046616">thymic</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045963">carcinoma</GlossaryTermRef> unless there are cancerous changes of the
<GlossaryTermRef href="CDR0000045682">epithelial</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef> that cover the organ. The term thymoma usually describes cancers that do not have obvious changes in the epithelial cells. Thymic carcinoma has clear-cut changes of the epithelial cells.    Other <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> that involve the thymus
<GlossaryTermRef href="CDR0000046386">gland</GlossaryTermRef> include <GlossaryTermRef href="CDR0000045368">lymphoma</GlossaryTermRef> (cancer that arises in cells of the <GlossaryTermRef href="CDR0000045764">lymphatic system</GlossaryTermRef>)
and <GlossaryTermRef href="CDR0000045695">germ cell tumors</GlossaryTermRef> (tumors that begin in cells that give rise to <GlossaryTermRef href="CDR0000257221">sperm</GlossaryTermRef> or
eggs); these tumors are not true thymomas or thymic <GlossaryTermRef href="CDR0000045963">carcinomas.</GlossaryTermRef>
			</Para>
			<Para id="_33">Thymomas and thymic carcinomas are rare in adults as well as children.  Various diseases and
<GlossaryTermRef href="CDR0000045090">syndromes</GlossaryTermRef> are associated with thymomas, including myasthenia gravis,
polymyositis, <GlossaryTermRef href="CDR0000045477">systemic lupus erythematosus</GlossaryTermRef>, rheumatoid <GlossaryTermRef href="CDR0000044188">arthritis,</GlossaryTermRef> thyroiditis,
and pure red <GlossaryTermRef href="CDR0000046476">cell</GlossaryTermRef> aplasia.  Endocrine (<GlossaryTermRef href="CDR0000045713">hormonal</GlossaryTermRef>) <GlossaryTermRef href="CDR0000407758">disorders</GlossaryTermRef> such as
<GlossaryTermRef href="CDR0000045717">hyperthyroidism,</GlossaryTermRef> Addison’s disease, and panhypopituitarism can also be
associated with a <GlossaryTermRef href="CDR0000046450">diagnosis</GlossaryTermRef> of thymoma or thymic carcinoma.
</Para>
			<Para id="_118">Cancer of the thymus may be caused by a specific <GlossaryTermRef href="CDR0000046470">chromosome</GlossaryTermRef> change. Every cell in the body contains <GlossaryTermRef href="CDR0000045671">DNA</GlossaryTermRef> (<GlossaryTermRef href="CDR0000046391">genetic</GlossaryTermRef> material stored inside chromosomes) that determines how the cell looks and acts. Cancer may develop when part of the DNA from chromosome 15 moves to another chromosome, or when chromosome 15 is broken.   This type of cancer may appear in the thymus or in other places along the midline of the body, including parts of the airway, the area between the <GlossaryTermRef href="CDR0000270740">lungs</GlossaryTermRef>, and the <GlossaryTermRef href="CDR0000046501">bladder.</GlossaryTermRef> It usually cannot be <GlossaryTermRef href="CDR0000318813">cured.</GlossaryTermRef>
			</Para>
			<Para id="_34">Thymomas and thymic carcinomas are usually located in the front part of the chest and are usually
discovered during a routine <GlossaryTermRef href="CDR0000304687">chest x-ray</GlossaryTermRef>.  <GlossaryTermRef href="CDR0000045022">Symptoms</GlossaryTermRef> can include cough,
difficulty with swallowing, tightness of the chest, chest pain, and shortness
of breath, although nonspecific symptoms may occur.  These tumors generally are
slow growing but are potentially <GlossaryTermRef href="CDR0000045741">invasive</GlossaryTermRef>, with cancer spreading to distant
<GlossaryTermRef href="CDR0000257523">organs</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef>.  <GlossaryTermRef href="CDR0000045570">Surgery</GlossaryTermRef> is performed with the goal of a complete
removal.  <GlossaryTermRef href="CDR0000044971">Radiation therapy</GlossaryTermRef> is necessary for patients with invasive thymoma or thymic carcinoma,
whether or not there has been surgery.  <GlossaryTermRef href="CDR0000045214">Chemotherapy</GlossaryTermRef> is usually reserved for
patients with advanced-<GlossaryTermRef href="CDR0000045885">stage</GlossaryTermRef> disease who have not responded to radiation
therapy or <GlossaryTermRef href="CDR0000046601">steroids.</GlossaryTermRef>  The <GlossaryTermRef href="CDR0000045849">prognosis</GlossaryTermRef> for patients with invasive thymoma or thymic carcinoma usually
is poor, although significantly higher <GlossaryTermRef href="CDR0000044301">survival rates</GlossaryTermRef> have been reported for
patients with tumors that have not spread to the surrounding areas. (Refer to
the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult <SummaryRef href="CDR0000269321" url="/cancertopics/pdq/treatment/thymoma/patient">Thymoma and Thymic Carcinoma Treatment</SummaryRef> for more information.)   
</Para>
		</SummarySection>
		<SummarySection id="_35">
			<Title>Tumors of the Heart</Title>
			<Para id="_36">
				<GlossaryTermRef href="CDR0000045847">Primary tumors</GlossaryTermRef> of the heart may include <GlossaryTermRef href="CDR0000045614">benign</GlossaryTermRef> (noncancerous) and <GlossaryTermRef href="CDR0000045772">malignant</GlossaryTermRef>
(<GlossaryTermRef href="CDR0000045333">cancerous</GlossaryTermRef>) <GlossaryTermRef href="CDR0000044248">teratoma</GlossaryTermRef> (a <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> made up of a mixture of <GlossaryTermRef href="CDR0000046683">tissues</GlossaryTermRef>),
<GlossaryTermRef href="CDR0000045872">rhabdomyosarcoma</GlossaryTermRef> (a tumor of muscle tissue), hemangioma (a usually <GlossaryTermRef href="CDR0000046079">benign tumor</GlossaryTermRef>
made up of <GlossaryTermRef href="CDR0000045020">blood vessels</GlossaryTermRef>), and <GlossaryTermRef href="CDR0000045221">chondrosarcoma</GlossaryTermRef> (a type of cancer that forms in
<GlossaryTermRef href="CDR0000044190">cartilage</GlossaryTermRef>).  <GlossaryTermRef href="CDR0000045022">Symptoms</GlossaryTermRef> include abnormalities of heart rhythm, enlargement of the
heart, <GlossaryTermRef href="CDR0000044669">fluid</GlossaryTermRef> in the pericardial sac, and <GlossaryTermRef href="CDR0000045143">congestive heart failure</GlossaryTermRef>.  Successful
treatment requires <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef> (which may include <GlossaryTermRef href="CDR0000046631">transplantation</GlossaryTermRef>) and <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef>
appropriate for the type of cancer that is present.
Benign tumors of heart muscle (rhabdomyomas) usually  shrink and  go away on their own. </Para>
		</SummarySection>
		<SummarySection id="_37">
			<Title>Mesothelioma</Title>
			<Para id="_38">
				<GlossaryTermRef href="CDR0000044323">Mesothelioma</GlossaryTermRef>,  an extremely rare cancer in children,  can involve the <GlossaryTermRef href="CDR0000046683">tissue</GlossaryTermRef> coverings of the <GlossaryTermRef href="CDR0000270740">lung</GlossaryTermRef>, the heart, or the
<GlossaryTermRef href="CDR0000046684">abdominal</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000257523">organs</GlossaryTermRef>.  These <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> can spread over the surface of organs, without
invading far into the underlying tissue, and may spread to nearby or distant
<GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef>.  Mesothelioma may develop after successful treatment of an earlier
<GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef>, especially after treatment with <GlossaryTermRef href="CDR0000044971">radiation</GlossaryTermRef>.  In adults, these tumors
have been associated with exposure to <GlossaryTermRef href="CDR0000046528">asbestos,</GlossaryTermRef> which was used as building
insulation.  The amount of exposure required to develop cancer is unknown, and
there is no information about the risk of children exposed to asbestos.  (Refer
to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult <SummaryRef href="CDR0000269299" url="/cancertopics/pdq/treatment/malignantmesothelioma/patient/">Malignant Mesothelioma Treatment</SummaryRef> for more
information.)   
</Para>
		</SummarySection>
	</SummarySection>
	<SummarySection id="_39">
		<Title>Abdominal  Cancers</Title>
		<Para id="_40">
			<GlossaryTermRef href="CDR0000046684">Abdominal</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000045333">cancers</GlossaryTermRef> include cancer of the adrenal cortex, <GlossaryTermRef href="CDR0000046325">kidney</GlossaryTermRef> cancer, <GlossaryTermRef href="CDR0000046604">stomach</GlossaryTermRef>
cancer, cancer of the <GlossaryTermRef href="CDR0000046254">pancreas,</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000046685">colorectal</GlossaryTermRef> cancer, <GlossaryTermRef href="CDR0000044233">carcinoid tumors</GlossaryTermRef> of the <GlossaryTermRef href="CDR0000270740">lung</GlossaryTermRef>
or <GlossaryTermRef href="CDR0000046335">intestine,</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044551">multiple endocrine neoplasia syndrome</GlossaryTermRef>.  These abdominal
cancers are discussed below.
</Para>
		<SummarySection id="_41">
			<Title>Cancer of the Adrenal Cortex</Title>
			<Para id="_42">The adrenal cortex is the outside layer of the <GlossaryTermRef href="CDR0000046678">adrenal glands</GlossaryTermRef>.  The adrenal
<GlossaryTermRef href="CDR0000046386">glands</GlossaryTermRef> are a pair of <GlossaryTermRef href="CDR0000257523">organs</GlossaryTermRef> near the front side edge of the <GlossaryTermRef href="CDR0000046325">kidney</GlossaryTermRef>; their
function is to produce <GlossaryTermRef href="CDR0000045713">hormones</GlossaryTermRef> such as <GlossaryTermRef href="CDR0000045295">glucocorticoid</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045404">epinephrine.</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045333">Cancers</GlossaryTermRef> in this area are classified as <GlossaryTermRef href="CDR0000045963">carcinomas</GlossaryTermRef> and <GlossaryTermRef href="CDR0000046217">adenomas.</GlossaryTermRef>  Adenomas are
generally <GlossaryTermRef href="CDR0000045614">benign,</GlossaryTermRef> whereas <GlossaryTermRef href="CDR0000367407">adrenocortical</GlossaryTermRef> carcinomas frequently secrete <GlossaryTermRef href="CDR0000045713">hormones</GlossaryTermRef>
and may cause the patient to develop masculine traits, regardless of the
patient’s gender.  <GlossaryTermRef href="CDR0000046245">Pediatric</GlossaryTermRef> patients with adrenocortical carcinoma often have
<GlossaryTermRef href="CDR0000046322">Li-Fraumeni syndrome</GlossaryTermRef>, an <GlossaryTermRef href="CDR0000045098">inherited</GlossaryTermRef> condition that predisposes family members to
multiple cancers, including <GlossaryTermRef href="CDR0000304766">breast</GlossaryTermRef> cancer, <GlossaryTermRef href="CDR0000045872">rhabdomyosarcoma,</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045395">osteosarcoma</GlossaryTermRef>
(cancer of the bone).
</Para>
			<Para id="_43">These <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> can involve the <GlossaryTermRef href="CDR0000046325">kidneys,</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000270740">lungs,</GlossaryTermRef> and bones.  <GlossaryTermRef href="CDR0000045570">Surgical</GlossaryTermRef> removal
should be attempted but may not always be possible if the <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> has spread
widely.  Additional treatment may include the use of an artificial hormone that
blocks the masculinizing effects of the tumor.  The <GlossaryTermRef href="CDR0000045849">prognosis</GlossaryTermRef> is generally
excellent for patients who have small tumors that have been completely
removed by <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef>, but prognosis can be poor for patients who have large
<GlossaryTermRef href="CDR0000045847">primary tumors</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045389">metastatic disease</GlossaryTermRef> (disease that has spread to other parts of
the body) at <GlossaryTermRef href="CDR0000046450">diagnosis.</GlossaryTermRef> Tumor <GlossaryTermRef href="CDR0000045885">stage</GlossaryTermRef> is an important factor affecting the chance of <GlossaryTermRef href="CDR0000454708">recovery</GlossaryTermRef> for children with adrenocortical tumors. When possible, repeat surgery should be done for tumors that come back and for tumors that spread to  the <GlossaryTermRef href="CDR0000044154">inferior vena cava</GlossaryTermRef> (a large  vein that empties into the heart).    (Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult <SummaryRef href="CDR0000062704" url="/cancertopics/pdq/treatment/adrenocortical/Patient">Adrenocortical
Carcinoma Treatment</SummaryRef> for more information.)
</Para>
		</SummarySection>
		<SummarySection id="_44">
			<Title>Kidney Cancer</Title>
			<Para id="_45">
				<GlossaryTermRef href="CDR0000044988">Renal cell carcinoma</GlossaryTermRef> (cancer of the <GlossaryTermRef href="CDR0000046325">kidney</GlossaryTermRef>) occurs rarely in children.  The
annual <GlossaryTermRef href="CDR0000046145">incidence</GlossaryTermRef> rate is approximately 4 cases per 2 million children.  Renal
cell carcinoma may be associated with <GlossaryTermRef href="CDR0000045563">von Hippel-Landau disease</GlossaryTermRef>, a <GlossaryTermRef href="CDR0000045983">hereditary</GlossaryTermRef>
condition.  Renal cell carcinoma has also been associated with <GlossaryTermRef href="CDR0000304692">tuberous
sclerosis</GlossaryTermRef>, a hereditary disease characterized by <GlossaryTermRef href="CDR0000045614">benign</GlossaryTermRef> (noncancerous)
fatty <GlossaryTermRef href="CDR0000046461">cysts</GlossaryTermRef> in the kidney.  It may also be associated with sickle cell anemia and/or <GlossaryTermRef href="CDR0000045418">neuroblastoma</GlossaryTermRef>. Renal cell carcinoma usually presents as an
<GlossaryTermRef href="CDR0000046684">abdominal</GlossaryTermRef> mass, and there may be discomfort, pain, or <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000046642">urine.</GlossaryTermRef>  The
<GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> can spread to the <GlossaryTermRef href="CDR0000270740">lungs</GlossaryTermRef>, bones, <GlossaryTermRef href="CDR0000046312">liver,</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef> and often
has spread before the <GlossaryTermRef href="CDR0000046450">diagnosis</GlossaryTermRef> is made.  The primary treatment includes total
<GlossaryTermRef href="CDR0000045570">surgical</GlossaryTermRef> removal of the kidney and associated lymph nodes.    Treatment of <GlossaryTermRef href="CDR0000044058">metastatic</GlossaryTermRef> disease (cancer in other parts of the body) is
presently unsatisfactory but usually includes the use of <GlossaryTermRef href="CDR0000046356">immune system</GlossaryTermRef>
modulators such as <GlossaryTermRef href="CDR0000045324">interferon-alfa</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045256">interleukin-2</GlossaryTermRef>.  Rare spontaneous
disappearance of lung <GlossaryTermRef href="CDR0000046710">metastasis</GlossaryTermRef> may occur with removal of the <GlossaryTermRef href="CDR0000045847">primary tumor</GlossaryTermRef>. 

Refer to the following <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summaries for more information about adult renal cell cancer and other types of childhood kidney cancers:</Para>
			<ItemizedList id="_129" Style="bullet">
				<ListItem>
					<SummaryRef href="CDR0000276462" url="/cancertopics/pdq/treatment/renalcell/Patient">Renal Cell Cancer</SummaryRef>
				</ListItem>
				<ListItem>
					<SummaryRef href="CDR0000415235" url="/cancertopics/pdq/treatment/wilms/Patient">Wilms' Tumor and Other Childhood Kidney Tumors</SummaryRef>
				</ListItem>
			</ItemizedList>
		</SummarySection>
		<SummarySection id="_46">
			<Title>Cancer of the Stomach</Title>
			<Para id="_47">The frequency of, and death rate from, <GlossaryTermRef href="CDR0000046604">stomach</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> has declined worldwide
over the past 50 years with the introduction of food preservation practices
such as refrigeration.  <GlossaryTermRef href="CDR0000045022">Symptoms</GlossaryTermRef> of stomach cancer include vague upper
<GlossaryTermRef href="CDR0000046684">abdominal</GlossaryTermRef> pain, which can be associated with poor appetite, and weight loss. 
Many individuals become <GlossaryTermRef href="CDR0000045360">anemic</GlossaryTermRef> but otherwise show no symptoms before the
development of <GlossaryTermRef href="CDR0000044058">metastatic</GlossaryTermRef> spread.  Other symptoms may include <GlossaryTermRef href="CDR0000390302">nausea,</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000390324">vomiting,</GlossaryTermRef>
change in <GlossaryTermRef href="CDR0000046500">bowel</GlossaryTermRef> habits, poor appetite and weakness, and <GlossaryTermRef href="CDR0000045706">Helicobacter pylori</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045364">infection.</GlossaryTermRef>
			</Para>
			<Para id="_48">Treatment should include <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef>.  For individuals who cannot have a complete
surgical removal of <GlossaryTermRef href="CDR0000046683">tissue,</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef> may be used along with
<GlossaryTermRef href="CDR0000045214">chemotherapy.</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045849">Prognosis</GlossaryTermRef> depends on the extent of the disease at the time of
<GlossaryTermRef href="CDR0000046450">diagnosis</GlossaryTermRef> and the success of treatment that is appropriate for the <GlossaryTermRef href="CDR0000044168">clinical</GlossaryTermRef>
situation.  Because of the rarity of stomach cancer in the <GlossaryTermRef href="CDR0000046245">pediatric</GlossaryTermRef> age group,
little information exists regarding treatment outcomes of children.  (Refer to
the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult <SummaryRef href="CDR0000271446" url="/cancertopics/pdq/treatment/gastric/Patient">Gastric Cancer Treatment</SummaryRef> for more information.)
</Para>
		</SummarySection>
		<SummarySection id="_49">
			<Title>Cancer of the Pancreas</Title>
			<Para id="_50">
				<GlossaryTermRef href="CDR0000046634">Tumors</GlossaryTermRef> of the <GlossaryTermRef href="CDR0000046254">pancreas</GlossaryTermRef> (a <GlossaryTermRef href="CDR0000046386">gland</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000045070">abdomen</GlossaryTermRef> that makes <GlossaryTermRef href="CDR0000046239">pancreatic juices</GlossaryTermRef> and
produces <GlossaryTermRef href="CDR0000045713">hormones</GlossaryTermRef>) are rare in children and adolescents.  Tumors included
within the general category can arise at any site in the pancreas.  Most
pancreatic tumors do not secrete <GlossaryTermRef href="CDR0000045713">hormones</GlossaryTermRef>, although some tumors secrete
<GlossaryTermRef href="CDR0000046187">insulin,</GlossaryTermRef> which can lead to <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef> of weakness, <GlossaryTermRef href="CDR0000321374">fatigue,</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000044114">hypoglycemia,</GlossaryTermRef> and
coma.  If a tumor interferes with the normal function of the <GlossaryTermRef href="CDR0000270855">islet cells</GlossaryTermRef> (<GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef>
in the pancreas that produce hormones), patients may have watery <GlossaryTermRef href="CDR0000306496">diarrhea</GlossaryTermRef> or
<GlossaryTermRef href="CDR0000044636">abnormalities</GlossaryTermRef> of salt balance.  At times, there is <GlossaryTermRef href="CDR0000044954">obstruction</GlossaryTermRef> of the head of
the pancreas, which is associated with <GlossaryTermRef href="CDR0000046328">jaundice</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045692">gastrointestinal</GlossaryTermRef> bleeding.
</Para>
			<Para id="_51">Treatment includes various <GlossaryTermRef href="CDR0000045570">surgical</GlossaryTermRef> procedures to remove the pancreas and
<GlossaryTermRef href="CDR0000046443">duodenum</GlossaryTermRef> or part of the pancreas.  For <GlossaryTermRef href="CDR0000046245">pediatric</GlossaryTermRef> patients, the effectiveness of <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef> is not known.  <GlossaryTermRef href="CDR0000045214">Chemotherapy</GlossaryTermRef> may be useful for treatment of
<GlossaryTermRef href="CDR0000045754">localized</GlossaryTermRef> or <GlossaryTermRef href="CDR0000044058">metastatic</GlossaryTermRef> pancreatic <GlossaryTermRef href="CDR0000045963">carcinoma</GlossaryTermRef>, although few cases have been
successfully treated.  <GlossaryTermRef href="CDR0000043983">Response rates</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044301">survival rates</GlossaryTermRef> generally are not
good. (Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult <SummaryRef href="CDR0000062957" url="/cancertopics/pdq/treatment/pancreatic/Patient">Pancreatic Cancer Treatment</SummaryRef> for more
information.)
</Para>
		</SummarySection>
		<SummarySection id="_52">
			<Title>Colorectal Cancer</Title>
			<Para id="_53">
				<GlossaryTermRef href="CDR0000045333">Cancer</GlossaryTermRef> of the large <GlossaryTermRef href="CDR0000046500">bowel</GlossaryTermRef> is rare in the <GlossaryTermRef href="CDR0000046245">pediatric</GlossaryTermRef> age group:  one person per one million younger than 20 years in the United States annually.   In children, more than half  of <GlossaryTermRef href="CDR0000044237">colon tumors</GlossaryTermRef> begin on the right side, compared with adults, who have more colon tumors on the left side. Colon cancer in children is often linked to a family<GlossaryTermRef href="CDR0000444983"> colorectal cancer</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045090">syndrome</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000045098">inherited</GlossaryTermRef> pattern.   There is an increasing risk of <GlossaryTermRef href="CDR0000046685">colorectal</GlossaryTermRef> cancer in members
of families with a <GlossaryTermRef href="CDR0000302456">family history</GlossaryTermRef> of <GlossaryTermRef href="CDR0000044046">intestinal</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045844">polyps,</GlossaryTermRef> which can lead to the
development of multiple <GlossaryTermRef href="CDR0000046217">adenomatous</GlossaryTermRef> polyps (<GlossaryTermRef href="CDR0000046079">benign tumors</GlossaryTermRef>).  Juvenile polyps
are not associated with an increased <GlossaryTermRef href="CDR0000046145">incidence</GlossaryTermRef> or risk of cancer.
</Para>
			<Para id="_54">Colorectal cancer usually presents with <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef> related to the site of the
tumor.  Changes in bowel habits are associated with tumors of the rectum or
lower colon.  Tumors of the right colon may cause more subtle symptoms but are
often associated with an <GlossaryTermRef href="CDR0000046684">abdominal</GlossaryTermRef>  mass, weight loss, decreased appetite, and
blood in the <GlossaryTermRef href="CDR0000046605">stool.</GlossaryTermRef>  Any tumor that causes complete <GlossaryTermRef href="CDR0000044954">obstruction</GlossaryTermRef> of the
large bowel can cause bowel perforation and spread of the tumor <GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef> within
the abdominal cavity.   
</Para>
			<Para id="_55">Colorectal <GlossaryTermRef href="CDR0000045963">carcinoma</GlossaryTermRef> is rarely <GlossaryTermRef href="CDR0000046450">diagnosed</GlossaryTermRef> in a pediatric patient; however, vague
<GlossaryTermRef href="CDR0000045692">gastrointestinal</GlossaryTermRef> symptoms should alert the <GlossaryTermRef href="CDR0000390246">physician</GlossaryTermRef> to investigate this
possibility.  Most patients present with evidence of <GlossaryTermRef href="CDR0000044058">metastatic</GlossaryTermRef> disease (cancer
that has spread to other body parts), either as gross tumor or as <GlossaryTermRef href="CDR0000044608">microscopic</GlossaryTermRef>
deposits in <GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef>, on the surface of the bowel, or other organs within
the <GlossaryTermRef href="CDR0000045070">abdomen</GlossaryTermRef>.  Complete <GlossaryTermRef href="CDR0000045570">surgical</GlossaryTermRef> removal should be the primary aim of the
<GlossaryTermRef href="CDR0000044306">surgeon,</GlossaryTermRef> but in most instances, this is impossible; removal of large portions of
tumor provides little benefit for the individuals with extensive metastatic
disease.  Most patients with microscopic metastatic disease generally develop
gross metastatic disease, and few individuals with metastatic disease at
diagnosis become long-term survivors.
</Para>
			<Para id="_56">Current <GlossaryTermRef href="CDR0000044737">therapy</GlossaryTermRef> includes the use of <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef> for <GlossaryTermRef href="CDR0000044083">rectal</GlossaryTermRef> and lower
colon tumors, in conjunction with <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef>.  (Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summaries on
adult <SummaryRef href="CDR0000062954" url="/cancertopics/pdq/treatment/colon/Patient">Colon</SummaryRef> and <SummaryRef href="CDR0000062959" url="/cancertopics/pdq/treatment/rectal/Patient">Rectal Cancer Treatment</SummaryRef> for more information.)
</Para>
		</SummarySection>
		<SummarySection id="_57">
			<Title>Carcinoid Tumors</Title>
			<Para id="_58">
				<GlossaryTermRef href="CDR0000044233">Carcinoid</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> can involve the lining of the <GlossaryTermRef href="CDR0000270740">lung</GlossaryTermRef> or the <GlossaryTermRef href="CDR0000045097">large</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046582">small bowel</GlossaryTermRef>
and may not be <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef>.  Most lung <GlossaryTermRef href="CDR0000046324">lesions</GlossaryTermRef> are not <GlossaryTermRef href="CDR0000045333">cancerous.</GlossaryTermRef>  Treatment of
<GlossaryTermRef href="CDR0000044058">metastatic</GlossaryTermRef> carcinoid tumors of the large bowel or <GlossaryTermRef href="CDR0000046604">stomach</GlossaryTermRef> becomes more
complicated and requires treatment similar to that given for <GlossaryTermRef href="CDR0000046685">colorectal</GlossaryTermRef> cancer.
(Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on <SummaryRef href="CDR0000258021" url="/cancertopics/pdq/treatment/gastrointestinalcarcinoid/Patient">Gastrointestinal Carcinoid Tumors Treatment</SummaryRef> for more information.)</Para>
		</SummarySection>
		<SummarySection id="_127">
			<Title>Gastrointestinal Stromal Cell Tumor</Title>
			<Para id="_128">
				<GlossaryTermRef href="CDR0000044998">Gastrointestinal stromal cell tumor</GlossaryTermRef> (GIST)  usually begins in <GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef> in the wall of the <GlossaryTermRef href="CDR0000046189">gastrointestinal tract</GlossaryTermRef>.  It may or may not be <GlossaryTermRef href="CDR0000045333">cancerous</GlossaryTermRef>.
This <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> is usually found in adults older than 40 years, although it can be found in children. GIST in children younger than 10 years is more common in girls. <GlossaryTermRef href="CDR0000045022">Symptoms</GlossaryTermRef> of GIST include <GlossaryTermRef href="CDR0000045360">anemia</GlossaryTermRef> caused by gastrointestinal bleeding.  Treatment of  GIST is different for children than  for adults. In children, unlike in adults, GIST is not caused by  changes in <GlossaryTermRef href="CDR0000045671">DNA</GlossaryTermRef> and is not treatable with <GlossaryTermRef href="CDR0000044893">imatinib mesylate</GlossaryTermRef> (Gleevec), a new kind of <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000348921">drug</GlossaryTermRef> that blocks these changes. Some adolescents and young adults with GIST  have tumors that are caused by DNA changes and  are treatable with imatinib mesylate. Patients in this age range should have their tumors examined for DNA changes.</Para>
		</SummarySection>
	</SummarySection>
	<SummarySection id="_59">
		<Title>Genital/Urinary Tumors</Title>
		<Para id="_60">Genital/<GlossaryTermRef href="CDR0000044093">urinary</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> include <GlossaryTermRef href="CDR0000046501">bladder</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044984">ovarian</GlossaryTermRef> cancer.  These
cancers are discussed below.
</Para>
		<SummarySection id="_61">
			<Title>Bladder Cancer</Title>
			<Para id="_62">
				<GlossaryTermRef href="CDR0000046501">Bladder</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> is extremely rare in children.  The most common <GlossaryTermRef href="CDR0000045963">carcinoma</GlossaryTermRef> to
involve the bladder is <GlossaryTermRef href="CDR0000046629">transitional cell carcinoma</GlossaryTermRef>, which generally presents
with <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000046642">urine.</GlossaryTermRef>  The <GlossaryTermRef href="CDR0000046450">diagnosis</GlossaryTermRef> and treatment of bladder cancer are the
same for children, adolescents, and adults.  Adolescents who develop this <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef>
are often prone to the development of other cancers.  Bladder cancer in
adolescents may develop as a <GlossaryTermRef href="CDR0000390292">late effect</GlossaryTermRef> of certain <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000348921">drugs</GlossaryTermRef> given
for other childhood tumors or <GlossaryTermRef href="CDR0000045343">leukemia.</GlossaryTermRef>  (Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summary on adult
<SummaryRef href="CDR0000062705" url="/cancertopics/pdq/treatment/bladder/Patient">Bladder Cancer Treatment</SummaryRef> for more information.)
</Para>
		</SummarySection>
		<SummarySection id="_63">
			<Title>Ovarian Cancer</Title>
			<Para id="_64">Most <GlossaryTermRef href="CDR0000044984">ovarian</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> in children are <GlossaryTermRef href="CDR0000045614">benign</GlossaryTermRef> (noncancerous). The most common <GlossaryTermRef href="CDR0000045333">cancers</GlossaryTermRef> that affect the <GlossaryTermRef href="CDR0000046687">ovaries</GlossaryTermRef> are of <GlossaryTermRef href="CDR0000046382">germ cell</GlossaryTermRef> origin (beginning in
<GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef> that give rise to <GlossaryTermRef href="CDR0000257221">sperm</GlossaryTermRef> or eggs); these are more common in children than
in adults.   Common <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef> of ovarian cancer include painful periods and pain in the <GlossaryTermRef href="CDR0000045070">abdomen</GlossaryTermRef>. Treatment is <GlossaryTermRef href="CDR0000045885">stage</GlossaryTermRef> related and may include <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef>, <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef>, and 
<GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef>. (Refer to the <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summaries on  <SummaryRef href="CDR0000062857" url="/cancertopics/pdq/treatment/extracranial-germ-cell/Patient">Childhood Extracranial Germ Cell Tumors Treatment, </SummaryRef>
				<SummaryRef href="CDR0000062963" url="/cancertopics/pdq/treatment/ovarianepithelial/Patient">Ovarian Epithelial Cancer Treatment</SummaryRef>, <SummaryRef href="CDR0000062967" url="/cancertopics/pdq/treatment/ovarian-germ-cell/Patient">Ovarian Germ Cell Tumors Treatment</SummaryRef> or <SummaryRef href="CDR0000062968" url="/cancertopics/pdq/treatment/ovarian-low-malignant-potential/Patient">Ovarian Low Malignant Potential Tumors Treatment</SummaryRef> for
more information.)   
</Para>
		</SummarySection>
		<SummarySection id="_120">
			<Title>Carcinoma of the Cervix and Vagina</Title>
			<Para id="_121">
				<GlossaryTermRef href="CDR0000045333">Cancer</GlossaryTermRef> of the <GlossaryTermRef href="CDR0000046133">cervix</GlossaryTermRef> and <GlossaryTermRef href="CDR0000046646">vagina</GlossaryTermRef> is very rare in children and adolescents.  Most young patients <GlossaryTermRef href="CDR0000046450">diagnosed</GlossaryTermRef> with cancer of the cervix or vagina were exposed to a <GlossaryTermRef href="CDR0000348921">drug</GlossaryTermRef> called <GlossaryTermRef href="CDR0000046021">diethylstilbestrol</GlossaryTermRef> (DES) before birth when it was given to their mothers.      DES was given to pregnant women between 1945 and
1970 to keep them from losing their babies (miscarriage).  
The most common <GlossaryTermRef href="CDR0000045022">symptom</GlossaryTermRef> of cancer of the cervix or vagina is <GlossaryTermRef href="CDR0000044308">vaginal</GlossaryTermRef> bleeding.  Treatment includes <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef> followed by <GlossaryTermRef href="CDR0000044971">radiation</GlossaryTermRef> and possibly <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef>.</Para>
		</SummarySection>
	</SummarySection>
	<SummarySection id="_65">
		<Title>Other Rare Childhood Cancers</Title>
		<Para id="_66">Other rare childhood <GlossaryTermRef href="CDR0000045333">cancers</GlossaryTermRef> include skin cancer, clear <GlossaryTermRef href="CDR0000046476">cell</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000045562">sarcoma</GlossaryTermRef> of tendon
sheaths, and cancer of unknown <GlossaryTermRef href="CDR0000045847">primary site</GlossaryTermRef>.  These other rare childhood
cancers are discussed below.
</Para>
		<SummarySection id="_67">
			<Title>Multiple Endocrine Neoplasia Syndrome</Title>
			<Para id="_68">
				<GlossaryTermRef href="CDR0000044551">Multiple endocrine neoplasia</GlossaryTermRef> (<GlossaryTermRef href="CDR0000044636">abnormal</GlossaryTermRef> and uncontrolled <GlossaryTermRef href="CDR0000046476">cell</GlossaryTermRef> growth) <GlossaryTermRef href="CDR0000045090">syndromes</GlossaryTermRef>
are familial <GlossaryTermRef href="CDR0000407758">disorders</GlossaryTermRef> that include <GlossaryTermRef href="CDR0000045333">cancerous</GlossaryTermRef> changes in more than  one endocrine
<GlossaryTermRef href="CDR0000257523">organ</GlossaryTermRef> at the same time (endocrine <GlossaryTermRef href="CDR0000046683">tissue</GlossaryTermRef> secretes <GlossaryTermRef href="CDR0000045713">hormones</GlossaryTermRef>).  These changes may
include <GlossaryTermRef href="CDR0000045956">hyperplasia</GlossaryTermRef> (overgrowth of tissue) or <GlossaryTermRef href="CDR0000045614">benign</GlossaryTermRef> (noncancerous) <GlossaryTermRef href="CDR0000046634">tumors.</GlossaryTermRef> 
The distinct involvement of multiple <GlossaryTermRef href="CDR0000046386">glandular</GlossaryTermRef> structures are referred to as
<GlossaryTermRef href="CDR0000270861">MEN-1</GlossaryTermRef> (Werner’s syndrome) which may involve tumors of the <GlossaryTermRef href="CDR0000046229">pituitary gland</GlossaryTermRef> and
<GlossaryTermRef href="CDR0000044554">parathyroid</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046678">adrenal</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046770">gastric,</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044074">pancreatic</GlossaryTermRef> structures.  MEN-2a (Sipple
syndrome) is associated with <GlossaryTermRef href="CDR0000044550">medullary thyroid carcinoma</GlossaryTermRef>, parathyroid
hyperplasia, and <GlossaryTermRef href="CDR0000046217">adenomas</GlossaryTermRef> as well as <GlossaryTermRef href="CDR0000322877">pheochromocytoma;</GlossaryTermRef> MEN-2b is associated
with medullary thyroid carcinoma, parathyroid hyperplasia, and adenomas as well
as pheochromocytoma, <GlossaryTermRef href="CDR0000257213">mucosal</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000046268">neuromas</GlossaryTermRef>, and ganglioneuromas.  An additional
complex is referred to as the Carney complex, which is associated with heart
and skin tumors.
</Para>
			<Para id="_69">Patients with the MEN-2b syndrome may have a slender body build, long and thin
extremities, a high arch <GlossaryTermRef href="CDR0000046253">palate,</GlossaryTermRef> and “funnel chest” (sunken chest) or an abnormally high arch in the foot. The lips may appear thickened because of tumors in the <GlossaryTermRef href="CDR0000257212">mucous membranes</GlossaryTermRef>.    In this
syndrome, medullary thyroid <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> may be particularly <GlossaryTermRef href="CDR0000046053">aggressive;</GlossaryTermRef> therefore,
the <GlossaryTermRef href="CDR0000046036">thyroid</GlossaryTermRef> should be removed  in infancy to prevent cancer in these affected children.
</Para>
			<Para id="_70">The outcome for patients with the MEN-1 syndrome is generally good, provided
adequate treatment can be obtained for parathyroid, pancreatic, and pituitary
tumors.  The outcome for patients with the MEN-2a syndrome is also generally
good, but the possibility exists for <GlossaryTermRef href="CDR0000045861">recurrence</GlossaryTermRef> of medullary thyroid carcinoma
and <GlossaryTermRef href="CDR0000322877">pheochromocytoma</GlossaryTermRef>.  Medullary thyroid cancer in children with MEN-2b may be difficult to <GlossaryTermRef href="CDR0000318813">cure</GlossaryTermRef>. For patients with the Carney complex, <GlossaryTermRef href="CDR0000045849">prognosis</GlossaryTermRef> depends
on how often heart and skin tumors recur.
</Para>
		</SummarySection>
		<SummarySection id="_71">
			<Title>Skin Cancer (Melanoma, Basal Cell Carcinoma, Squamous Cell Carcinoma)</Title>
			<Para id="_72">
				<GlossaryTermRef href="CDR0000045135">Melanoma</GlossaryTermRef> is thought to be the most common skin <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> in children, followed by
<GlossaryTermRef href="CDR0000046516">basal cell</GlossaryTermRef> and <GlossaryTermRef href="CDR0000046595">squamous cell carcinomas</GlossaryTermRef>.  The <GlossaryTermRef href="CDR0000046145">incidence</GlossaryTermRef> of melanoma in children
and adolescents represents approximately 1% of the new cases of melanoma that
are <GlossaryTermRef href="CDR0000046450">diagnosed</GlossaryTermRef> annually in the United States.  In all instances, melanoma in the
<GlossaryTermRef href="CDR0000046245">pediatric</GlossaryTermRef> population is similar to that of adults in relation to site of
presentation, <GlossaryTermRef href="CDR0000045022">symptoms,</GlossaryTermRef> description, spread, and <GlossaryTermRef href="CDR0000045849">prognosis</GlossaryTermRef>,  but may grow faster in children than in adults.
</Para>
			<Para id="_73">The most common cause of skin cancer of any type is exposure to the <GlossaryTermRef href="CDR0000045934">ultraviolet</GlossaryTermRef>
(UV) portion of sunlight.  Other causes may be related to chemical
<GlossaryTermRef href="CDR0000046487">carcinogenesis,</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000045072">radiation</GlossaryTermRef> exposure, <GlossaryTermRef href="CDR0000046357">immunodeficiency,</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045727">immunosuppression.</GlossaryTermRef> 
The person who is most likely to develop a melanoma is easily sunburned, has
poor tanning ability, and generally has light hair, blue eyes, and pale skin. 
Worldwide, there is an increasing incidence of both melanoma and <GlossaryTermRef href="CDR0000046261">nonmelanoma
skin cancers</GlossaryTermRef>.  Melanoma presents as a relatively flat, dark-colored <GlossaryTermRef href="CDR0000046324">lesion</GlossaryTermRef>
that may enlarge, penetrate the skin, or <GlossaryTermRef href="CDR0000046283">metastasize.</GlossaryTermRef>
			</Para>
			<Para id="_74">
				<GlossaryTermRef href="CDR0000045135">Melanomas</GlossaryTermRef> may be congenital (present at birth).  They are sometimes associated
with large congenital black spots known as <GlossaryTermRef href="CDR0000046292">melanocytic</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000046271">nevi</GlossaryTermRef>, which may cover
the trunk and thigh.  Children with <GlossaryTermRef href="CDR0000045983">hereditary</GlossaryTermRef> immunodeficiencies have an
increased lifetime risk of developing melanoma.
</Para>
			<Para id="_75">Individuals with atypical <GlossaryTermRef href="CDR0000046286">moles,</GlossaryTermRef> which include raised <GlossaryTermRef href="CDR0000046324">lesions</GlossaryTermRef> (that may or may
not bleed) and various color hues (brown, tan, pink, black) are at an increased
risk of having melanoma and having children affected by these <GlossaryTermRef href="CDR0000045846">premalignant</GlossaryTermRef>
lesions.  <GlossaryTermRef href="CDR0000046515">Basal cell carcinoma</GlossaryTermRef> generally appears as a raised lump or <GlossaryTermRef href="CDR0000269469">ulcerated</GlossaryTermRef>
lesion, usually in areas with previous sun exposure.  Squamous cell carcinomas
are usually reddened lesions with varying degrees of scaling or crusting; they
have an appearance similar to eczema, <GlossaryTermRef href="CDR0000045364">infections,</GlossaryTermRef> trauma, or <GlossaryTermRef href="CDR0000044219">psoriasis.</GlossaryTermRef>
			</Para>
			<Para id="_76">Basal and <GlossaryTermRef href="CDR0000046595">squamous cell carcinomas</GlossaryTermRef> are generally <GlossaryTermRef href="CDR0000318813">curable</GlossaryTermRef> with <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef> alone,
but the treatment of melanoma requires greater consideration because of its
potential for <GlossaryTermRef href="CDR0000046710">metastasis.</GlossaryTermRef>  Surgery for melanoma depends on the size, site,
level of invasion, and metastatic extent or stage of the <GlossaryTermRef href="CDR0000046634">tumor.</GlossaryTermRef>  
If the melanoma has not spread beyond the lymph nodes,  <GlossaryTermRef href="CDR0000045587">adjuvant</GlossaryTermRef>
				<GlossaryTermRef href="CDR0000415238">biologic therapy</GlossaryTermRef> may be given to increase the chances of a <GlossaryTermRef href="CDR0000318813">cure</GlossaryTermRef>. If the melanoma has spread beyond the lymph nodes, treatment may include a combination of <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef> and biologic therapy.  There are <GlossaryTermRef href="CDR0000045961">clinical trials</GlossaryTermRef> for melanoma available to children  aged 10 years or older.  Information about ongoing clinical trials is available from the <ExternalRef xref="http://cancer.gov/clinicaltrials">NCI Web site</ExternalRef>.</Para>
		</SummarySection>
		<SummarySection id="_123">
			<Title>Chordoma</Title>
			<Para id="_124">
				<GlossaryTermRef href="CDR0000045297">Chordoma</GlossaryTermRef> is a very rare type of bone <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef>  that may develop  along the <GlossaryTermRef href="CDR0000415914">spine</GlossaryTermRef> at any point from the base of the skull to the tailbone.  Chordomas start in clusters of <GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef> leftover from <GlossaryTermRef href="CDR0000396787">spinal column</GlossaryTermRef> development in the <GlossaryTermRef href="CDR0000044202">embryo</GlossaryTermRef>. These cells normally disappear, but  very rarely they remain and grow into tumors. In children and adolescents, especially girls, chordomas often develop in the clivus, a bone at the base of the skull. <GlossaryTermRef href="CDR0000045022">Symptoms</GlossaryTermRef> vary and may include pain and <GlossaryTermRef href="CDR0000373935">nerve</GlossaryTermRef>   trouble.  When chordoma recurs, it usually comes back in the same area, but may appear in the <GlossaryTermRef href="CDR0000270740">lungs</GlossaryTermRef> or other areas of bone.</Para>
			<Para id="_125">
				<GlossaryTermRef href="CDR0000044930">Standard treatment</GlossaryTermRef> includes <GlossaryTermRef href="CDR0000045570">surgery</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef>. The best results are seen with <GlossaryTermRef href="CDR0000270726">proton beam therapy</GlossaryTermRef>, a special kind of high-energy radiation that is different from an <GlossaryTermRef href="CDR0000045944">x-ray</GlossaryTermRef>.</Para>
		</SummarySection>
		<SummarySection id="_79">
			<Title>Cancer of Unknown Primary Site</Title>
			<Para id="_126">
				<GlossaryTermRef href="CDR0000045333">Cancer</GlossaryTermRef> can form in any <GlossaryTermRef href="CDR0000046683">tissue</GlossaryTermRef> of the body and can spread from the <GlossaryTermRef href="CDR0000045847">primary</GlossaryTermRef> site (the place where the cancer first began to grow) to other parts of the body. Cancer that has spread from the place in which it started to other parts of the body is called <GlossaryTermRef href="CDR0000045389">metastatic cancer</GlossaryTermRef>. Metastatic cancer <GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef> usually look like cells in the type of tissue where the cancer  began. For example, <GlossaryTermRef href="CDR0000444971">breast cancer</GlossaryTermRef> cells that spread to the <GlossaryTermRef href="CDR0000270740">lung</GlossaryTermRef> look like breast cancer cells, not <GlossaryTermRef href="CDR0000445043">lung cancer</GlossaryTermRef> cells. Sometimes metastatic cancer cells are found in the body, but tests do not find a primary <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef>. If  cancer cells are found in the body but the place where the cancer started cannot be identified, the disease is called <GlossaryTermRef href="CDR0000046134">cancer of unknown primary site</GlossaryTermRef>. Treatment is based on what the cancer cells look like under a microscope, the patient's <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef>, and the extent of the cancer in the body. Treatment is usually <GlossaryTermRef href="CDR0000045214">chemotherapy</GlossaryTermRef> or <GlossaryTermRef href="CDR0000044971">radiation therapy</GlossaryTermRef>.</Para>
		</SummarySection>
	</SummarySection>
	<SummarySection id="_112">
		<SectMetaData>
			<SectionType>Changes to summary</SectionType>
		</SectMetaData>
		<Title>Changes to This Summary (10/27/2006)</Title>
		<Para id="_113">The <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef>
			<GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> information summaries are reviewed regularly and updated as
new information becomes available.  This section describes the latest
changes made to this summary as of the date above.</Para>
		<Para id="_122">Editorial changes were made to this summary.</Para>
	</SummarySection>
	<SummarySection id="_ToLearnMore_3">
		<Title>To Learn More</Title>
		<Para id="_ToLearnMore_15">
			<Emphasis>
				<Strong>Call</Strong>
			</Emphasis>
		</Para>
		<Para id="_ToLearnMore_16">For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 9:00 a.m. to 4:30 p.m.  Deaf and hard-of-hearing callers with TTY equipment may call 1-800-332-8615.  The call is free and a trained Cancer Information Specialist is available to answer your questions.</Para>
		<Para id="_ToLearnMore_17">
			<Emphasis>
				<Strong>Web sites and Organizations</Strong>
			</Emphasis>
		</Para>
		<Para id="_ToLearnMore_18">The <ExternalRef xref="http://cancer.gov">NCI Web site</ExternalRef> provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support and resources for cancer patients and their families.  There are also many other places where people can get materials and information about cancer treatment and services.  Local hospitals may have information on local and regional agencies that offer information about finances, getting to and from treatment, receiving care at home, and dealing with problems associated with cancer treatment.</Para>
		<Para id="_ToLearnMore_19">
			<Emphasis>
				<Strong>Publications</Strong>
			</Emphasis>
		</Para>
		<Para id="_ToLearnMore_20">The NCI has booklets and other materials for patients, health professionals, and the public.  These publications discuss types of cancer, methods of cancer treatment, coping with cancer, and clinical trials.  Some publications provide information on tests for cancer, cancer causes and prevention, cancer statistics, and NCI research activities.  NCI materials on these and other topics may be ordered online or printed directly from the <ExternalRef xref="https://cissecure.nci.nih.gov/ncipubs">NCI Publications Locator</ExternalRef>. These materials can also be ordered by telephone from the Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237), TTY at 1-800-332-8615.</Para>
		<Para id="_ToLearnMore_21">
			<Emphasis>
				<Strong>LiveHelp</Strong>
			</Emphasis>
		</Para>
		<Para id="_ToLearnMore_22">The NCI's LiveHelp service, a program available on several of the Institute's Web sites, provides Internet users with the ability to chat online with an Information Specialist.  The service is available from 9:00 a.m. to 11:00 p.m.  Eastern time, Monday through Friday.  Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer.</Para>
		<Para id="_ToLearnMore_23">
			<Emphasis>
				<Strong>Write</Strong>
			</Emphasis>
		</Para>
		<Para id="_ToLearnMore_24">For more information from the NCI, please write to this address:</Para>
		<ItemizedList id="_ToLearnMore_13" Style="simple">
			<ListItem>NCI Public Inquiries Office</ListItem>
			<ListItem>Suite 3036A</ListItem>
			<ListItem>6116 Executive Boulevard, MSC8322</ListItem>
			<ListItem>Bethesda, MD 20892-8322</ListItem>
		</ItemizedList>
	</SummarySection>
	<SummarySection id="_AboutPDQ_2">
		<Title>About PDQ</Title>
		<Para id="_AboutPDQ_13">
			<Emphasis>
				<Strong>PDQ is a comprehensive cancer database available on NCI's Web site.</Strong>
			</Emphasis>
		</Para>
		<Para id="_AboutPDQ_14">PDQ is the National Cancer Institute's (NCI's) comprehensive cancer information database.  Most of the information contained in PDQ is available online at  <ExternalRef xref="http://cancer.gov">NCI's Web site</ExternalRef>.  PDQ is provided as a service of the NCI.  The NCI is part of the National Institutes of Health, the federal government's focal point for biomedical research. </Para>
		<Para id="_AboutPDQ_3">
			<Emphasis>
				<Strong>PDQ contains cancer information summaries. </Strong>
			</Emphasis>
		</Para>
		<Para id="_AboutPDQ_4">The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine.  Most summaries are available in two versions.  The health professional versions provide detailed information written in technical language.  The patient versions are written in easy-to-understand, nontechnical language.  Both versions provide current and accurate cancer information. </Para>
		<Para id="_AboutPDQ_5">
			<Emphasis>
				<Strong>The PDQ cancer information summaries are developed by cancer experts and reviewed regularly.</Strong>
			</Emphasis>
		</Para>
		<Para id="_AboutPDQ_6">Editorial Boards made up of experts in oncology and related specialties are responsible for writing and maintaining the cancer information summaries.  The summaries are reviewed regularly and changes are made as new information becomes available.  The date on each summary ("Date Last Modified") indicates the time of the most recent change.</Para>
		<Para id="_AboutPDQ_7">
			<Emphasis>
				<Strong>PDQ also contains information on clinical trials.</Strong>
			</Emphasis>
		</Para>
		<Para id="_AboutPDQ_8">In the United States, about two-thirds of children with cancer are treated in a clinical trial at some point in their illness.  A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another.  Trials are based on past studies and what has been learned in the laboratory.  Each trial answers certain scientific questions in order to find new and better ways to help cancer patients.  During treatment clinical trials, information is collected about new treatments, the risks involved, and how well they do or do not work.  If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard."</Para>
		<Para id="_AboutPDQ_9">Listings of clinical trials are included in PDQ and are available online at <ExternalRef xref="http://cancer.gov/clinical_trials">NCI's Web site</ExternalRef>.  Descriptions of the trials are available in health professional and patient versions.  For additional help in locating a childhood cancer clinical trial, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237), TTY at 1-800-332-8615.</Para>
		<Para id="_AboutPDQ_15">
			<Emphasis>
				<Strong>The PDQ database contains listings of groups specializing in clinical trials. 

</Strong>
			</Emphasis>
		</Para>
		<Para id="_AboutPDQ_10">The Children's Oncology Group (COG) is the major group that organizes clinical trials for childhood cancers in the United States.  Information about contacting COG is available on the <ExternalRef xref="http://cancer.gov">NCI Web site</ExternalRef> or from the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237), TTY at 1-800-332-8615.</Para>
		<Para id="_AboutPDQ_11">
			<Emphasis>
				<Strong>The PDQ database contains listings of cancer health professionals and hospitals with cancer programs.</Strong>
			</Emphasis>
		</Para>
		<Para id="_AboutPDQ_12">Because cancer in children and adolescents is rare, the majority of children with cancer are treated by health professionals specializing in childhood cancers, at hospitals or cancer centers with special facilities to treat them.  The PDQ database contains listings of health professionals who specialize in childhood cancer and listings of hospitals with cancer programs.  For help locating childhood cancer health professionals or a hospital with cancer programs, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237), TTY at 1-800-332-8615.</Para>
	</SummarySection>
	<PatientVersionOf ref="CDR0000062872"/>
	<DateLastModified>2006-10-27</DateLastModified>
</Summary>
